Browse by Journal Title

2024

Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia.
Mochmann, L.H., Treue, D., Bockmayr, M., Silva, P., Zasada, C., Mastrobuoni, G., Bayram, S., Forbes, M., Jurmeister, P., Liebig, S., Blau, O., Schleich, K., Splettstoesser, B., Nordmann, T.M., von der Heide, E.K., Isaakidis, K., Schulze, V., Busch, C., Siddiq, H., Schlee, C., Hester, S., Fransecky, L., Neumann, M., Kempa, S., Klauschen, F. and Baldus, C.D.
Cancer Gene Therapy 31 (9): 1344-1356. September 2024

Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model.
Wang, F., Zhang, S., Sun, F., Chen, W., Liu, C., Dong, H., Cui, B., Li, L., Sun, C., Du, W., Liu, B., Fan, W., Deng, J., Schmitt, C.A., Wang, X. and Du, J.
Cancer Gene Therapy 31 (8): 1135-1150. August 2024

2016

CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.
Nguyen-Hoai, T., Pham-Duc, M., Gries, M., Dörken, B., Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 23 (6): 162-167. June 2016

2012

CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC.
Nguyen-Hoai, T., Hohn, O., Vu, M.D., Baldenhofer, G., Sayed Ahmed, M.S., Doerken, B., Norley, S., Lipp, M., Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 19 (12): 880-887. December 2012

CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.
Nguyen-Hoai, T., Baldenhofer, G., Sayed Ahmed, M.S., Pham-Duc, M., Vu, M.D., Lipp, M., Doerken, B., Pezzutto, A. and Westermann, J.
Cancer Gene Therapy 19 (1): 69-76. January 2012

2007

CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity.
Westermann, J., Nguyen-Hoai, T., Baldenhofer, G., Höpken, U.E., Lipp, M., Dörken, B. and Pezzutto, A.
Cancer Gene Therapy 14 (6): 523-532. June 2007

2003

Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapy.
Zeisig, R., Ress, A., Fichtner, I. and Walther, W.
Cancer Gene Therapy 10 (4): 302-311. April 2003

2002

Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski, P., Stein, U., Scheffer, G.L. and Lage, H.
Cancer Gene Therapy 9 (7): 579-586. July 2002

Adenovirus-mediated gene transfer of P161NK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo.
Tamm, I., Schumacher, A., Karawajew, L., Ruppert, V., Arnold, W., Nuessler, A.K., Neuhaus, P., Doerken, B. and Wolff, G.
Cancer Gene Therapy 9 : 641-650. 1 January 2002

2001

Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
Buttgereit, P., Schakowski, F., Maerten, A., Brand, K., Renoth, S., Ziske, C., Schoettker, B., Ebert, O., Schroers, R. and Schmidt-Wolf, I.G.H.
Cancer Gene Therapy 8 : 430-439. 1 January 2001

2000

Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
Buttgereit, P., Weineck, S., Ropke, G., Marten, A., Brand, K., Heinicke, T., Caselmann, W.H., Huhn, D. and Schmidt-Wolf, I.
Cancer Gene Therapy 7 : 1145-1155. 1 August 2000

mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors.
Walther, W., Stein, U., Fichtner, I., Alexander, M., Shoemaker, R.H. and Schlag, P.M.
Cancer Gene Therapy 7 (6): 893-900. 1 June 2000

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
Kammertoens, T., Gelbmann, W., Karle, P., Alton, K., Saller, R., Salmons, B., Guenzburg, W.H. and Uckert, W.
Cancer Gene Therapy 7 (4): 629-636. 1 April 2000

1997

Liver associated toxicity of the hsv tk/gcv approach and adenoviral vectors.
Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M.A., Strauss, M. and Doerken, B.
Cancer Gene Therapy 4 (1): 9-16. 1 January 1997

1995

Vectors in cancer therapy: how will they deliver.
Blaese, M., Blankenstein, T., Brenner, M., Cohen-Haguenauer, O., Gansbacher, B., Russell, S., Sorrentino, B. and Velu, T.
Cancer Gene Therapy 2 (4): 291-297. 1 January 1995